Top Markets
#1 Black Phoenix Black Phoenix +333.52%
#2 Islamic Coin Islamic Coin +158.18%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +21.05%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.65%
#6 DOVU DOVU +15.63%
#7 Palladium Network Palladium Network +8.75%
#8 Pons Pons +7.99%
#9 stake.link stake.link +7.92%
#10 Movement Movement +6.59%
Coin of the day
Black Phoenix Black Phoenix
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rankning i aktier #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aktiekurs
$0.0009
Senast synkroniserad: 2025-05-27
Marknadsvärde
$1.15K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Kategori

Healthcare
Vinst för Arch Therapeutics, Inc. (ARTH)
Vinst i Jun 2024 TTM: $-12.26M
Enligt de senaste finansiella rapporterna från Arch Therapeutics, Inc. är företagets nuvarande vinst $-12.26M. År 2022 hade företaget en vinst på $-5.28M, en ökning jämfört med vinsten år 2021 som var $-6.24M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Arch Therapeutics, Inc. från 2011 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $-12.26M 75.61%
2023 $-6.98M 32.35%
2022 $-5.28M -15.46%
2021 $-6.24M 33.02%
2020 $-4.69M 3.16%
2019 $-4.55M -5.53%
2018 $-4.81M -38.19%
2017 $-7.79M 29.98%
2016 $-5.99M 103.30%
2015 $-2.95M -63.80%
2014 $-8.14M 339.25%
2013 $-1.85M 4,963.48%
2012 $-36.61K 626.84%
2011 $-5.04K 0.00%
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -43,115.92%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -16,007.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -24,611.12%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR